Ibrexafungerp citrate (MK-3118; SCY078; MK3118; SCY-078; Brexafemme), the citrate salt of Ibrexafungerp, is a β-1,3-glucan synthesis inhibitor approved as an antifungal medication to treat vulvovaginal candidiasis (VVC) (vaginal yeast infection).

纯度：≥98%

CAS：1965291-08-0